Hedqin®

Therapeutic Segment:
Anti-Malarial

Generic Name:
Dihydroartemisinin/Piperaquine Phosphate

Description:
HEDQIN is the fixed dose combination therapy of Dihydroartemisinin & Piperaquine Phosphate used as first-line treatment of uncomplicated malaria. Dihydroartemisinin is the most active metabolite of all artemisinin compounds and Piperaquine Phosphate belongs to the 4-amino- quinoline.

Indication:
World Health Organization (WHO) strongly recommends Dihydroartemisinin + Piperaquine Phosphate (HEDQIN) as a latest ACT option to use as first line treatment for the uncomplicated P. falciparum malaria including multi-drug resistant strains. Dihydroartemisinin + Piperaquine Phosphate is also effective against P. vivax malaria and has strong action on gametocytes. Piperaquine is also used as prophylaxis due to the advantage of its longer half life.

Strength:

  • 40mg/320mg

Formulation:

  • Tablets

Pack Size:

  • 8’s